Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases.

Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454(7203):428–435. https://doi.org/10.1038/nature07201

doi: 10.1038/nature07201 pubmed: 18650913

Headland SE, Norling LV (2015) The resolution of inflammation: principles and challenges. Semin Immunol 27(3):149–160. https://doi.org/10.1016/j.smim.2015.03.014

doi: 10.1016/j.smim.2015.03.014 pubmed: 25911383

Furman D et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25(12):1822–1832. https://doi.org/10.1038/s41591-019-0675-0

doi: 10.1038/s41591-019-0675-0 pubmed: 31806905 pmcid: 7147972

Garza-Lombó C et al (2019) Arsenic-induced neurotoxicity: a mechanistic appraisal. J Biol Inorg Chem 24(8):1305–1316. https://doi.org/10.1007/s00775-019-01740-8

doi: 10.1007/s00775-019-01740-8 pubmed: 31748979 pmcid: 6903391

Lane CA, Hardy J, Schott JM (2018) Alzheimer’s disease. Eur J Neurol 25(1):59–70. https://doi.org/10.1111/ene.13439

doi: 10.1111/ene.13439 pubmed: 28872215

Crous-Bou M et al (2017) Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9(1):71. https://doi.org/10.1186/s13195-017-0297-z

doi: 10.1186/s13195-017-0297-z pubmed: 28899416 pmcid: 5596480

Silva MVF et al (2019) Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 26(1):33. https://doi.org/10.1186/s12929-019-0524-y

doi: 10.1186/s12929-019-0524-y pubmed: 31072403 pmcid: 6507104

Laurent C, Buée L, Blum D (2018) Tau and neuroinflammation: what impact for Alzheimer’s disease and tauopathies? Biomed J 41(1):21–33. https://doi.org/10.1016/j.bj.2018.01.003

doi: 10.1016/j.bj.2018.01.003 pubmed: 29673549 pmcid: 6138617

Barron M et al (2017) A state of delirium: deciphering the effect of inflammation on tau pathology in Alzheimer’s disease. Exp Gerontol 94:103–107. https://doi.org/10.1016/j.exger.2016.12.006

doi: 10.1016/j.exger.2016.12.006 pubmed: 27979768 pmcid: 5479936

Qiu S et al (2021) Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment. Mol Neurodegener 16(1):64. https://doi.org/10.1186/s13024-021-00488-7

doi: 10.1186/s13024-021-00488-7 pubmed: 34526055 pmcid: 8442347

Guo JT et al (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 22(14):5900–5909. https://doi.org/10.1523/jneurosci.22-14-05900.2002

doi: 10.1523/jneurosci.22-14-05900.2002 pubmed: 12122052 pmcid: 6757908

Zhang Z, Wang M, Liu X (2022) C-reactive protein and risk of Alzheimer’s disease. Neurobiol Aging 109:259–263. https://doi.org/10.1016/j.neurobiolaging.2021.08.010

doi: 10.1016/j.neurobiolaging.2021.08.010 pubmed: 34538509

Matsubara E et al (1990) Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 28(4):561–567. https://doi.org/10.1002/ana.410280414

doi: 10.1002/ana.410280414 pubmed: 2147546

Calvo-Rodriguez M et al (2020) Role of toll like receptor 4 in Alzheimer’s disease. Front Immunol 11:1588. https://doi.org/10.3389/fimmu.2020.01588

doi: 10.3389/fimmu.2020.01588 pubmed: 32983082 pmcid: 7479089

Sarlus H, Heneka MT (2017) Microglia in Alzheimer’s disease. J Clin Invest 127(9):3240–3249. https://doi.org/10.1172/jci90606

doi: 10.1172/jci90606 pubmed: 28862638 pmcid: 5669553

Ozben T, Ozben S (2019) Neuro-inflammation and anti-inflammatory treatment options for Alzheimer’s disease. Clin Biochem 72:87–89. https://doi.org/10.1016/j.clinbiochem.2019.04.001

doi: 10.1016/j.clinbiochem.2019.04.001 pubmed: 30954437

Cai Z, Hussain MD, Yan LJ (2014) Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease. Int J Neurosci 124(5):307–321. https://doi.org/10.3109/00207454.2013.833510

doi: 10.3109/00207454.2013.833510 pubmed: 23930978

Cornejo F et al (2018) Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer’s disease pathophysiology. Brain Behav Immun 69:336–350. https://doi.org/10.1016/j.bbi.2017.12.007

doi: 10.1016/j.bbi.2017.12.007 pubmed: 29246456

Demirci S et al (2017) The serum levels of resistin and its relationship with other proinflammatory cytokines in patients with Alzheimer’s disease. Clin Psychopharmacol Neurosci 15(1):59–63. https://doi.org/10.9758/cpn.2017.15.1.59

doi: 10.9758/cpn.2017.15.1.59 pubmed: 28138112 pmcid: 5290717

Perea JR, Bolós M, Avila J (2020) Microglia in Alzheimer's disease in the context of tau pathology. Biomolecules 10(10). https://doi.org/10.3390/biom10101439

Farina C, Aloisi F, Meinl E (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28(3):138–145. https://doi.org/10.1016/j.it.2007.01.005

doi: 10.1016/j.it.2007.01.005 pubmed: 17276138

Medeiros R, LaFerla FM (2013) Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239:133–138. https://doi.org/10.1016/j.expneurol.2012.10.007

doi: 10.1016/j.expneurol.2012.10.007 pubmed: 23063604

Olabarria M et al (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s disease. Glia 58(7):831–838. https://doi.org/10.1002/glia.20967

doi: 10.1002/glia.20967 pubmed: 20140958

Kaur D, Sharma V, Deshmukh R (2019) Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease. Inflammopharmacology 27(4):663–677. https://doi.org/10.1007/s10787-019-00580-x

doi: 10.1007/s10787-019-00580-x pubmed: 30874945

Wang C et al (2022) Forsythoside A mitigates Alzheimer’s-like pathology by inhibiting ferroptosis-mediated neuroinflammation via Nrf2/GPX4 axis activation. Int J Biol Sci 18(5):2075–2090. https://doi.org/10.7150/ijbs.69714

doi: 10.7150/ijbs.69714 pubmed: 35342364 pmcid: 8935224

McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28(5):639–647. https://doi.org/10.1016/j.neurobiolaging.2006.03.013

doi: 10.1016/j.neurobiolaging.2006.03.013 pubmed: 16697488

Szekely CA et al (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer’s disease: a systematic review. Neuroepidemiology 23(4):159–169. https://doi.org/10.1159/000078501

doi: 10.1159/000078501 pubmed: 15279021

Yu F et al (2015) Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation. J Neuroinflammation 12:122. https://doi.org/10.1186/s12974-015-0343-3

doi: 10.1186/s12974-015-0343-3 pubmed: 26104799 pmcid: 4490619

Liu J et al (2023) APP/PS1 gene-environmental cadmium interaction aggravates the progression of Alzheimer’s disease in mice via the blood-brain barrier, amyloid-β, and inflammation. J Alzheimers Dis 94(1):115–136. https://doi.org/10.3233/jad-221205

doi: 10.3233/jad-221205 pubmed: 37248897

Tripathi PN et al (2019) Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem 85:82–96. https://doi.org/10.1016/j.bioorg.2018.12.017

doi: 10.1016/j.bioorg.2018.12.017 pubmed: 30605887

Rai SN et al (2018) Commentary: Mild endoplasmic reticulum stress ameliorates lpopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization. Front Aging Neurosci 10:192. https://doi.org/10.3389/fnagi.2018.00192

doi: 10.3389/fnagi.2018.00192 pubmed: 29988480 pmcid: 6026620

Schneider RB, Iourinets J, Richard IH (2017) Parkinson’s disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag 7(6):365–376. https://doi.org/10.2217/nmt-2017-0028

doi: 10.2217/nmt-2017-0028 pubmed: 29160144

Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1–12. https://doi.org/10.1016/j.cger.2019.08.002

doi: 10.1016/j.cger.2019.08.002 pubmed: 31733690

Dorsey ER et al (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3-s8. https://doi.org/10.3233/jpd-181474

doi: 10.3233/jpd-181474 pubmed: 30584159 pmcid: 6311367

Jacobs ML et al (2016) Risk factor profile in Parkinson’s disease subtype with REM sleep behavior disorder. J Parkinsons Dis 6(1):231–237. https://doi.org/10.3233/jpd-150725

doi: 10.3233/jpd-150725 pubmed: 26889635

Zhao Y et al (2023) Metal exposure and risk of Parkinson disease: a systematic review and meta-analysis. Am J Epidemiol 192(7):1207–1223. https://doi.org/10.1093/aje/kwad082

doi: 10.1093/aje/kwad082 pubmed: 37022311 pmcid: 10326611

Moreno JA et al (2011) Manganese-induced NF-kappaB activation and nitrosative stress is decreased by estrogen in juvenile mice. Toxicol Sci 122(1):121–133. https://doi.org/10.1093/toxsci/kfr091

doi: 10.1093/toxsci/kfr091 pubmed: 21512103 pmcid: 3143469

Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53(2):1181–1194. https://doi.org/10.1007/s12035-014-9070-5

doi: 10.1007/s12035-014-9070-5 pubmed: 25598354

Lee E et al (2019) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 26(2):213–228. https://doi.org/10.1038/s41418-018-0124-5

doi: 10.1038/s41418-018-0124-5 pubmed: 29786072

Pajares M et al (2020) Inflammation in Parkinson's disease: mechanisms and therapeutic implications. Cells 9(7). https://doi.org/10.3390/cells9071687

Lee HJ et al (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285(12):9262–9272. https://doi.org/10.1074/jbc.M109.081125

doi: 10.1074/jbc.M109.081125 pubmed: 20071342 pmcid: 2838344

Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease. Acta Neuropathol 114(3):231–241. https://doi.org/10.1007/s00401-007-0244-3

doi: 10.1007/s00401-007-0244-3 pubmed: 17576580

Gu XL et al (2010) Astrocytic expression of Parkinson’s disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol Brain 3:12. https://doi.org/10.1186/1756-6606-3-12

doi: 10.1186/1756-6606-3-12 pubmed: 20409326 pmcid: 2873589

Lastres-Becker I et al (2012) α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson’s disease. Hum Mol Genet 21(14):3173–3192. https://doi.org/10.1093/hmg/dds143

doi: 10.1093/hmg/dds143 pubmed: 22513881

Yun SP et al (2018) Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease. Nat Med 24(7):931–938. https://doi.org/10.1038/s41591-018-0051-5

doi: 10.1038/s41591-018-0051-5 pubmed: 29892066 pmcid: 6039259

Klegeris A et al (2006) Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. Faseb J 20(12):2000–2008. https://doi.org/10.1096/fj.06-6183com

doi: 10.1096/fj.06-6183com pubmed: 17012252

Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481–487. https://doi.org/10.1038/nature21029

doi: 10.1038/nature21029 pubmed: 28099414 pmcid: 5404890

Verma DK et al (2021) Alpha-synuclein preformed fibrils induce cellular senescence in Parkinson's disease models. Cells 10(7). https://doi.org/10.3390/cells10071694

Wakabayashi K et al (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol 99(1):14–20. https://doi.org/10.1007/pl00007400

doi: 10.1007/pl00007400 pubmed: 10651022

Rai SN et al (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 71:41–49. https://doi.org/10.1016/j.jchemneu.2015.12.002

doi: 10.1016/j.jchemneu.2015.12.002 pubmed: 26686287

Walker FO (2007) Huntington’s disease. Lancet 369(9557):218–228. https://doi.org/10.1016/s0140-6736(07)60111-1

doi: 10.1016/s0140-6736(07)60111-1 pubmed: 17240289

McColgan P, Tabrizi SJ (2018) Huntington’s disease: a clinical review. Eur J Neurol 25(1):24–34. https://doi.org/10.1111/ene.13413

doi: 10.1111/ene.13413 pubmed: 28817209

Reiner A et al (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85(15):5733–5737. https://doi.org/10.1073/pnas.85.15.5733

doi: 10.1073/pnas.85.15.5733 pubmed: 2456581 pmcid: 281835

Ha AD, Fung VS (2012) Huntington’s disease. Curr Opin Neurol 25(4):491–498. https://doi.org/10.1097/WCO.0b013e3283550c97

doi: 10.1097/WCO.0b013e3283550c97 pubmed: 22772878

Ross CA, Tabrizi SJ (2011) Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83–98. https://doi.org/10.1016/s1474-4422(10)70245-3

doi: 10.1016/s1474-4422(10)70245-3 pubmed: 21163446

Ramakrishna K et al (2023) WNT-β catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective. Diseases 11(3). https://doi.org/10.3390/diseases11030089

Moscovitch-Lopatin M et al (2010) Optimization of an HTRF assay for the detection of soluble mutant huntingtin in human buffy coats: a potential biomarker in blood for Huntington disease. PLoS Curr 2:Rrn1205. https://doi.org/10.1371/currents.RRN1205

doi: 10.1371/currents.RRN1205 pubmed: 21278900 pmcid: 3015780

Möller T (2010) Neuroinflammation in Huntington’s disease. J Neural Transm 117(8):1001–1008. https://doi.org/10.1007/s00702-010-0430-7 . (Vienna)

doi: 10.1007/s00702-010-0430-7 pubmed: 20535620

Hsiao HY et al (2013) A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington’s disease. Hum Mol Genet 22(9):1826–1842. https://doi.org/10.1093/hmg/ddt036

doi: 10.1093/hmg/ddt036 pubmed: 23372043

Subhramanyam CS et al (2019) Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol 94:112–120. https://doi.org/10.1016/j.semcdb.2019.05.004

doi: 10.1016/j.semcdb.2019.05.004 pubmed: 31077796

Palazuelos J et al (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity. Brain 132(Pt 11):3152–3164. https://doi.org/10.1093/brain/awp239

doi: 10.1093/brain/awp239 pubmed: 19805493

Pavese N et al (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66(11):1638–1643. https://doi.org/10.1212/01.wnl.0000222734.56412.17

doi: 10.1212/01.wnl.0000222734.56412.17 pubmed: 16769933

Saba J et al (2022) Neuroinflammation in Huntington’s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol 20(6):1116–1143. https://doi.org/10.2174/1570159x19666211201094608

doi: 10.2174/1570159x19666211201094608 pubmed: 34852742 pmcid: 9886821

Crotti A, Glass CK (2015) The choreography of neuroinflammation in Huntington’s disease. Trends Immunol 36(6):364–373. https://doi.org/10.1016/j.it.2015.04.007

doi: 10.1016/j.it.2015.04.007 pubmed: 26001312 pmcid: 4786070

Hsiao HY et al (2014) Inhibition of soluble tumor necrosis factor is therapeutic in Huntington’s disease. Hum Mol Genet 23(16):4328–4344. https://doi.org/10.1093/hmg/ddu151

doi: 10.1093/hmg/ddu151 pubmed: 24698979

Tai YF et al (2007) Microglial activation in presymptomatic Huntington’s disease gene carriers. Brain 130(Pt 7):1759–1766. https://doi.org/10.1093/brain/awm044

doi: 10.1093/brain/awm044 pubmed: 17400599

Valadão PAC et al (2020) Inflammation in Huntington’s disease: a few new twists on an old tale. J Neuroimmunol 348:577380. https://doi.org/10.1016/j.jneuroim.2020.577380

doi: 10.1016/j.jneuroim.2020.577380 pubmed: 32896821

Martino G et al (2002) Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol 1(8):499–509. https://doi.org/10.1016/s1474-4422(02)00223-5

doi: 10.1016/s1474-4422(02)00223-5 pubmed: 12849335

Thompson AJ et al (2018) Multiple sclerosis. Lancet 391(10130):1622–1636. https://doi.org/10.1016/s0140-6736(18)30481-1

doi: 10.1016/s0140-6736(18)30481-1 pubmed: 29576504

Browne P et al (2014) Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology 83(11):1022–1024. https://doi.org/10.1212/wnl.0000000000000768

doi: 10.1212/wnl.0000000000000768 pubmed: 25200713 pmcid: 4162299

Noseworthy JH et al (2000) Multiple sclerosis. N Engl J Med 343(13):938–952. https://doi.org/10.1056/nejm200009283431307

doi: 10.1056/nejm200009283431307 pubmed: 11006371

Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7(3):115–121. https://doi.org/10.1016/s1471-4914(00)01909-2

doi: 10.1016/s1471-4914(00)01909-2 pubmed: 11286782

Baranzini SE, Oksenberg JR (2017) The genetics of multiple sclerosis: from 0 to 200 in 50 years. Trends Genet 33(12):960–970. https://doi.org/10.1016/j.tig.2017.09.004

doi: 10.1016/j.tig.2017.09.004 pubmed: 28987266 pmcid: 5701819

Howard J, Trevick S, Younger DS (2016) Epidemiology of multiple sclerosis. Neurol Clin 34(4):919–939. https://doi.org/10.1016/j.ncl.2016.06.016

doi: 10.1016/j.ncl.2016.06.016 pubmed: 27720001

Sadovnick AD, Baird PA (1988) The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology 38(6):990–991. https://doi.org/10.1212/wnl.38.6.990

doi: 10.1212/wnl.38.6.990 pubmed: 3368082

Bagnato F, Hametner S, Welch EB (2013) Visualizing iron in multiple sclerosis. Magn Reson Imaging 31(3):376–384. https://doi.org/10.1016/j.mri.2012.11.011

doi: 10.1016/j.mri.2012.11.011 pubmed: 23347601 pmcid: 4776767

Pedchenko TV, LeVine SM (1998) Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 84(2):188–197. https://doi.org/10.1016/s0165-5728(97)00256-7

doi: 10.1016/s0165-5728(97)00256-7 pubmed: 9628462

Milo R et al (2020) The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis. Mult Scler 26(8):876–886. https://doi.org/10.1177/1352458519886943

doi: 10.1177/1352458519886943 pubmed: 31682184

Gharagozloo M et al (2017) NLR-dependent regulation of inflammation in multiple sclerosis. Front Immunol 8:2012. https://doi.org/10.3389/fimmu.2017.02012

doi: 10.3389/fimmu.2017.02012 pubmed: 29403486

Reale M et al (2015) Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients. Int Immunopharmacol 29(1):152–157. https://doi.org/10.1016/j.intimp.2015.06.034

doi: 10.1016/j.intimp.2015.06.034 pubmed: 26209886

Reale M et al (2012) Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients. Int J Mol Sci 13(10):12656–12664. https://doi.org/10.3390/ijms131012656

doi: 10.3390/ijms131012656 pubmed: 23202919 pmcid: 3497293

Voet S, Prinz M, van Loo G (2019) Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med 25(2):112–123. https://doi.org/10.1016/j.molmed.2018.11.005

doi: 10.1016/j.molmed.2018.11.005 pubmed: 30578090

Stampanoni Bassi M et al (2018) Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course. J Neurol 265(11):2540–2547. https://doi.org/10.1007/s00415-018-8994-5

doi: 10.1007/s00415-018-8994-5 pubmed: 30167879

Lévesque SA et al (2016) Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. J Exp Med 213(6):929–949. https://doi.org/10.1084/jem.20151437

doi: 10.1084/jem.20151437 pubmed: 27139491 pmcid: 4886360

Sutton C et al (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203(7):1685–1691. https://doi.org/10.1084/jem.20060285

doi: 10.1084/jem.20060285 pubmed: 16818675 pmcid: 2118338

Storer PD et al (2005) Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J Neuroimmunol 161(1–2):113–122. https://doi.org/10.1016/j.jneuroim.2004.12.015

doi: 10.1016/j.jneuroim.2004.12.015 pubmed: 15748950

Cignarella F et al (2020) TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol 140(4):513–534. https://doi.org/10.1007/s00401-020-02193-z

doi: 10.1007/s00401-020-02193-z pubmed: 32772264 pmcid: 7498497

Rossi S et al (2014) Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis. J Neuroinflammation 11:32. https://doi.org/10.1186/1742-2094-11-32

doi: 10.1186/1742-2094-11-32 pubmed: 24548694 pmcid: 3975953

Centonze D et al (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 29(11):3442–3452. https://doi.org/10.1523/jneurosci.5804-08.2009

doi: 10.1523/jneurosci.5804-08.2009 pubmed: 19295150 pmcid: 6665268

Stampanoni Bassi M et al (2018) Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis. J Neuroinflammation 15(1):108. https://doi.org/10.1186/s12974-018-1150-4

doi: 10.1186/s12974-018-1150-4 pubmed: 29655371 pmcid: 5899838

Hulisz D (2018) Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care 24(15 Suppl):S320-s326

pubmed: 30207670

Hardiman O et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https://doi.org/10.1038/nrdp.2017.71

doi: 10.1038/nrdp.2017.71 pubmed: 28980624

Figueroa-Romero C et al (2020) Early life metal dysregulation in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 7(6):872–882. https://doi.org/10.1002/acn3.51006

doi: 10.1002/acn3.51006 pubmed: 32438517 pmcid: 7318091

Peters S et al (2021) Blood metal levels and amyotrophic lateral sclerosis risk: a prospective cohort. Ann Neurol 89(1):125–133. https://doi.org/10.1002/ana.25932

doi: 10.1002/ana.25932 pubmed: 33068316

Kiernan MC et al (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942–955. https://doi.org/10.1016/s0140-6736(10)61156-7

doi: 10.1016/s0140-6736(10)61156-7 pubmed: 21296405

Wang T et al (2022) Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death Differ 29(6):1187–1198. https://doi.org/10.1038/s41418-021-00910-z

doi: 10.1038/s41418-021-00910-z pubmed: 34857917

White WL (2011) Erratum to: Why I hate the index finger. Hand (N Y) 6(2):233. https://doi.org/10.1007/s11552-011-9321-0

doi: 10.1007/s11552-011-9321-0 pubmed: 21776199

Thompson AG, Turner MR (2019) Untangling neuroinflammation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 90(12):1303–1304. https://doi.org/10.1136/jnnp-2019-321242

doi: 10.1136/jnnp-2019-321242 pubmed: 31296587

Mitchell RM et al (2009) A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72(1):14–19. https://doi.org/10.1212/01.wnl.0000333251.36681.a5

doi: 10.1212/01.wnl.0000333251.36681.a5 pubmed: 18987350

McCauley ME, Baloh RH (2019) Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 137(5):715–730. https://doi.org/10.1007/s00401-018-1933-9

doi: 10.1007/s00401-018-1933-9 pubmed: 30465257

Lyon MS et al (2019) Inflammation, immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve 59(1):10–22. https://doi.org/10.1002/mus.26289

doi: 10.1002/mus.26289 pubmed: 29979464

McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26(4):459–470. https://doi.org/10.1002/mus.10191

doi: 10.1002/mus.10191 pubmed: 12362410

Mishra PS et al (2017) Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia. J Neuroinflammation 14(1):251. https://doi.org/10.1186/s12974-017-1028-x

doi: 10.1186/s12974-017-1028-x pubmed: 29246232 pmcid: 5732516

Crisafulli SG et al (2018) Therapeutic strategies under development targeting inflammatory mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol 55(4):2789–2813. https://doi.org/10.1007/s12035-017-0532-4

doi: 10.1007/s12035-017-0532-4 pubmed: 28455693

Henkel JS et al (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55(2):221–235. https://doi.org/10.1002/ana.10805

doi: 10.1002/ana.10805 pubmed: 14755726

Turner MR et al (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15(3):601–609. https://doi.org/10.1016/j.nbd.2003.12.012

doi: 10.1016/j.nbd.2003.12.012 pubmed: 15056468

Beers DR et al (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103(43):16021–6. https://doi.org/10.1073/pnas.0607423103

doi: 10.1073/pnas.0607423103 pubmed: 17043238 pmcid: 1613228

Boillée S, VandeVelde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52(1):39–59. https://doi.org/10.1016/j.neuron.2006.09.018

doi: 10.1016/j.neuron.2006.09.018 pubmed: 17015226

Zhao W et al (2010) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58(2):231–243. https://doi.org/10.1002/glia.20919

doi: 10.1002/glia.20919 pubmed: 19672969 pmcid: 2784168

Frakes AE et al (2014) Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron 81(5):1009–1023. https://doi.org/10.1016/j.neuron.2014.01.013

doi: 10.1016/j.neuron.2014.01.013 pubmed: 24607225 pmcid: 3978641

Källstig E, McCabe BD, Schneider BL (2021) The Links between ALS and NF-κB. Int J Mol Sci 22(8). https://doi.org/10.3390/ijms22083875

Johansson A et al (2007) Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. J Neurol Sci 255(1–2):17–22. https://doi.org/10.1016/j.jns.2007.01.057

doi: 10.1016/j.jns.2007.01.057 pubmed: 17346749

Johann S et al (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63(12):2260–2273. https://doi.org/10.1002/glia.22891

doi: 10.1002/glia.22891 pubmed: 26200799

Guttenplan KA et al (2020) Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat Commun 11(1):3753. https://doi.org/10.1038/s41467-020-17514-9

doi: 10.1038/s41467-020-17514-9 pubmed: 32719333 pmcid: 7385161

Meissner F, Molawi K, Zychlinsky A (2010) Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A 107(29):13046–13050. https://doi.org/10.1073/pnas.1002396107

doi: 10.1073/pnas.1002396107 pubmed: 20616033 pmcid: 2919927

Gugliandolo A et al (2018) NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model. Inflammation 41(1):93–103. https://doi.org/10.1007/s10753-017-0667-5

doi: 10.1007/s10753-017-0667-5 pubmed: 28936769

Pasinelli P et al (1998) Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc Natl Acad Sci U S A 95(26):15763–15768. https://doi.org/10.1073/pnas.95.26.15763

doi: 10.1073/pnas.95.26.15763 pubmed: 9861044 pmcid: 28118

Lehmann S et al (2018) Expression profile of pattern recognition receptors in skeletal muscle of SOD1((G93A)) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients. Neuropathol Appl Neurobiol 44(6):606–627. https://doi.org/10.1111/nan.12483

doi: 10.1111/nan.12483 pubmed: 29575052

Yu CH et al (2020) TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell 183(3):636-649.e18. https://doi.org/10.1016/j.cell.2020.09.020

doi: 10.1016/j.cell.2020.09.020 pubmed: 33031745 pmcid: 7599077

Chen S et al (2017) RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death. Apoptosis 22(5):626–638. https://doi.org/10.1007/s10495-017-1358-2

doi: 10.1007/s10495-017-1358-2 pubmed: 28289909

Ito Y et al (2016) RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353(6299):603–608. https://doi.org/10.1126/science.aaf6803

doi: 10.1126/science.aaf6803 pubmed: 27493188 pmcid: 5444917

Xiong L et al (2022) Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radic Biol Med 178:125–133. https://doi.org/10.1016/j.freeradbiomed.2021.11.031

doi: 10.1016/j.freeradbiomed.2021.11.031 pubmed: 34871763

Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity. Lancet Neurol 13(3):330–338. https://doi.org/10.1016/s1474-4422(13)70278-3

doi: 10.1016/s1474-4422(13)70278-3 pubmed: 24556010 pmcid: 4418502

Pandey S et al (2018) Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson’s disease (PD). Clin Chim Acta 485:258–261. https://doi.org/10.1016/j.cca.2018.07.021

doi: 10.1016/j.cca.2018.07.021 pubmed: 30006282

Hall AH (2002) Chronic arsenic poisoning. Toxicol Lett 128(1–3):69–72. https://doi.org/10.1016/s0378-4274(01)00534-3

doi: 10.1016/s0378-4274(01)00534-3 pubmed: 11869818

Kaur S, Kamli MR, Ali A (2011) Role of arsenic and its resistance in nature. Can J Microbiol 57(10):769–774. https://doi.org/10.1139/w11-062

doi: 10.1139/w11-062 pubmed: 21936668

Garelick H et al (2008) Arsenic pollution sources. Rev Environ Contam Toxicol 197:17–60. https://doi.org/10.1007/978-0-387-79284-2_2

doi: 10.1007/978-0-387-79284-2_2 pubmed: 18982996

Vibol S, Hashim JH, Sarmani S (2015) Neurobehavioral effects of arsenic exposure among secondary school children in the Kandal Province, Cambodia. Environ Res 137:329–337. https://doi.org/10.1016/j.envres.2014.12.001

doi: 10.1016/j.envres.2014.12.001 pubmed: 25601736

Das AK et al (2010) Protective effect of Corchorus olitorius leaves on sodium arsenite-induced toxicity in experimental rats. Food Chem Toxicol 48(1):326–335. https://doi.org/10.1016/j.fct.2009.10.020

doi: 10.1016/j.fct.2009.10.020 pubmed: 19852998

Osuna-Martínez CC et al (2021) Arsenic in waters, soils, sediments, and biota from Mexico: An environmental review. Sci Total Environ 752:142062. https://doi.org/10.1016/j.scitotenv.2020.142062

doi: 10.1016/j.scitotenv.2020.142062 pubmed: 33207489

Sinha D, Prasad P (2020) Health effects inflicted by chronic low-level arsenic contamination in groundwater: A global public health challenge. J Appl Toxicol 40(1):87–131. https://doi.org/10.1002/jat.3823

doi: 10.1002/jat.3823 pubmed: 31273810

Mukherjee SC et al (2003) Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J Environ Sci Health A Tox Hazard Subst Environ Eng 38(1):165–183. https://doi.org/10.1081/ese-120016887

doi: 10.1081/ese-120016887 pubmed: 12635825

Brinkel J, Khan MH, Kraemer A (2009) A systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh. Int J Environ Res Public Health 6(5):1609–1619. https://doi.org/10.3390/ijerph6051609

doi: 10.3390/ijerph6051609 pubmed: 19543409 pmcid: 2697931

Rodríguez VM et al (1998) Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environ Health Perspect 106(8):487–491. https://doi.org/10.1289/ehp.106-1533203

doi: 10.1289/ehp.106-1533203 pubmed: 9681976 pmcid: 1533203

Mochizuki H (2019) Arsenic Neurotoxicity in Humans. Int J Mol Sci 20(14). https://doi.org/10.3390/ijms20143418

Li D et al (2009) Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos. Aquat Toxicol 91(3):229–237. https://doi.org/10.1016/j.aquatox.2008.11.007

doi: 10.1016/j.aquatox.2008.11.007 pubmed: 19110324

Wang X et al (2021) Association of arsenic exposure and cognitive impairment: a population-based cross-sectional study in China. Neurotoxicology 82:100–107. https://doi.org/10.1016/j.neuro.2020.11.009

doi: 10.1016/j.neuro.2020.11.009 pubmed: 33249123

WHO (2022) Standard for arsenic in drinking water. Web. https://www.who.int/news-room/fact-sheets/detail/arsenic

Wang B et al (2022) Arsenic exposure analysis for children living in central China: from ingestion exposure to biomarkers. Chemosphere 287(Pt 2):132194. https://doi.org/10.1016/j.chemosphere.2021.132194

doi: 10.1016/j.chemosphere.2021.132194 pubmed: 34509767

Srivastava S et al (2009) Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice. Toxicol Appl Pharmacol 241(1):90–100. https://doi.org/10.1016/j.taap.2009.08.004

doi: 10.1016/j.taap.2009.08.004 pubmed: 19682479 pmcid: 4414341

Saha S et al (2018) Ameliorative role of genistein against age-dependent chronic arsenic toxicity in murine brains via the regulation of oxidative stress and inflammatory signaling cascades. J Nutr Biochem 55:26–40. https://doi.org/10.1016/j.jnutbio.2017.11.010

doi: 10.1016/j.jnutbio.2017.11.010 pubmed: 29331881

Mao J et al (2016) Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway. Toxicol Appl Pharmacol 303:79–89. https://doi.org/10.1016/j.taap.2016.05.003

doi: 10.1016/j.taap.2016.05.003 pubmed: 27174766

Prasad P, Sinha D (2017) Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors. Environ Sci Pollut Res Int 24(12):11708–11721. https://doi.org/10.1007/s11356-017-8744-8

doi: 10.1007/s11356-017-8744-8 pubmed: 28332085

Mo J et al (2011) Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: assessment by real-time PCR arrays. Int J Environ Res Public Health 8(6):2090–2108. https://doi.org/10.3390/ijerph8062090

doi: 10.3390/ijerph8062090 pubmed: 21776218 pmcid: 3138013

Dutta K, Prasad P, Sinha D (2015) Chronic low level arsenic exposure evokes inflammatory responses and DNA damage. Int J Hyg Environ Health 218(6):564–574. https://doi.org/10.1016/j.ijheh.2015.06.003

doi: 10.1016/j.ijheh.2015.06.003 pubmed: 26118750

Stigger F et al (2013) Inflammatory response and oxidative stress in developing rat brain and its consequences on motor behavior following maternal administration of LPS and perinatal anoxia. Int J Dev Neurosci 31(8):820–827. https://doi.org/10.1016/j.ijdevneu.2013.10.003

doi: 10.1016/j.ijdevneu.2013.10.003 pubmed: 24140242

Liu X et al (2021) Microglia-derived IL-1β promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK/eIF2α/ATF4/CHOP upon arsenic exposure. J Hazard Mater 417:125997. https://doi.org/10.1016/j.jhazmat.2021.125997

doi: 10.1016/j.jhazmat.2021.125997 pubmed: 34229406

Sun X et al (2017) Arsenic affects inflammatory cytokine expression in Gallus gallus brain tissues. BMC Vet Res 13(1):157. https://doi.org/10.1186/s12917-017-1066-8

doi: 10.1186/s12917-017-1066-8 pubmed: 28583123 pmcid: 5460324

Gan R et al (2023) Curcumin alleviates arsenic trioxide-induced inflammation and pyroptosis via the NF-κB/NLRP3 signaling pathway in the hypothalamus of ducks. Biol Trace Elem Res 201(5):2503–2511. https://doi.org/10.1007/s12011-022-03321-4

doi: 10.1007/s12011-022-03321-4 pubmed: 35737258

Tutkun L et al (2019) Arsenic-induced inflammation in workers. Mol Biol Rep 46(2):2371–2378. https://doi.org/10.1007/s11033-019-04694-x

doi: 10.1007/s11033-019-04694-x pubmed: 30783936

Gong G, O’Bryant SE (2010) The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis Assoc Disord 24(4):311–6. https://doi.org/10.1097/WAD.0b013e3181d71bc7

doi: 10.1097/WAD.0b013e3181d71bc7 pubmed: 20473132

Sewell J, Östör A (2022) Emerging injectable therapies for osteoarthritis. Expert Opin Emerg Drugs 27(3):311–320. https://doi.org/10.1080/14728214.2022.2125506

doi: 10.1080/14728214.2022.2125506 pubmed: 36102303

Exley C (2013) Human exposure to aluminium. Environ Sci Process Impacts 15(10):1807–1816. https://doi.org/10.1039/c3em00374d

doi: 10.1039/c3em00374d pubmed: 23982047

Niu Q (2018) Overview of the relationship between aluminum exposure and health of human being. Adv Exp Med Biol 1091:1–31. https://doi.org/10.1007/978-981-13-1370-7_1

doi: 10.1007/978-981-13-1370-7_1 pubmed: 30315446

Alasfar RH, Isaifan RJ (2021) Aluminum environmental pollution: the silent killer. Environ Sci Pollut Res Int 28(33):44587–44597. https://doi.org/10.1007/s11356-021-14700-0

doi: 10.1007/s11356-021-14700-0 pubmed: 34196863 pmcid: 8364537

Yokel RA (2000) The toxicology of aluminum in the brain: a review. Neurotoxicology 21(5):813–828

pubmed: 11130287

Fernandes RM et al (2020) Preclinical evidences of aluminum-induced neurotoxicity in hippocampus and pre-frontal cortex of rats exposed to low doses. Ecotoxicol Environ Saf 206:111139. https://doi.org/10.1016/j.ecoenv.2020.111139

doi: 10.1016/j.ecoenv.2020.111139 pubmed: 32861963

Walton JR (2009) Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicology 30(2):182–193. https://doi.org/10.1016/j.neuro.2008.11.012

doi: 10.1016/j.neuro.2008.11.012 pubmed: 19109991

Markesbery WR et al (1984) Brain trace element concentrations in aging. Neurobiol Aging 5(1):19–28. https://doi.org/10.1016/0197-4580(84)90081-2

doi: 10.1016/0197-4580(84)90081-2 pubmed: 6738782

Becaria A, Campbell A, Bondy SC (2002) Aluminum as a toxicant. Toxicol Ind Health 18(7):309–320. https://doi.org/10.1191/0748233702th157oa

doi: 10.1191/0748233702th157oa pubmed: 15068131

Meiri H, Banin E, Roll M (1991) Aluminum ingestion–is it related to dementia? Rev Environ Health 9(4):191–205. https://doi.org/10.1515/reveh.1991.9.4.191

doi: 10.1515/reveh.1991.9.4.191 pubmed: 1842454

Rusina R et al (2011) Higher aluminum concentration in Alzheimer’s disease after Box-Cox data transformation. Neurotox Res 20(4):329–333. https://doi.org/10.1007/s12640-011-9246-y

doi: 10.1007/s12640-011-9246-y pubmed: 21567285

Shin RW, Lee VM, Trojanowski JQ (1995) Neurofibrillary pathology and aluminum in Alzheimer’s disease. Histol Histopathol 10(4):969–978

pubmed: 8574016

Liu H et al (2020) Neurotoxicity of aluminum oxide nanoparticles and their mechanistic role in dopaminergic neuron injury involving p53-related pathways. J Hazard Mater 392:122312. https://doi.org/10.1016/j.jhazmat.2020.122312

doi: 10.1016/j.jhazmat.2020.122312 pubmed: 32105957

Bondy SC (2010) The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 31(5):575–581. https://doi.org/10.1016/j.neuro.2010.05.009

doi: 10.1016/j.neuro.2010.05.009 pubmed: 20553758 pmcid: 2946821

Yang L et al (2017) Effect of PGE(2)-EP(s) pathway on primary cultured rat neuron injury caused by aluminum. Oncotarget 8(54):92004–92017. https://doi.org/10.18632/oncotarget.21122

Cao Z et al (2019) Lycopene attenuates aluminum-induced hippocampal lesions by inhibiting oxidative stress-mediated inflammation and apoptosis in the rat. J Inorg Biochem 193:143–151. https://doi.org/10.1016/j.jinorgbio.2019.01.017

doi: 10.1016/j.jinorgbio.2019.01.017 pubmed: 30743053

Zaky A et al (2013) Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation. BMC Neurosci 14:26. https://doi.org/10.1186/1471-2202-14-26

doi: 10.1186/1471-2202-14-26 pubmed: 23497276 pmcid: 3616857

Pogue AI et al (2017) Systemic inflammation in C57BL/6J mice receiving dietary aluminum sulfate; up-regulation of the pro-inflammatory cytokines IL-6 and TNFα, C-reactive protein (CRP) and miRNA-146a in blood sErum. J Alzheimers Dis Parkinsonism 7(6). https://doi.org/10.4172/2161-0460.1000403

Hao W et al (2021) Aluminum impairs cognitive function by activating DDX3X-NLRP3-mediated pyroptosis signaling pathway. Food Chem Toxicol 157:112591. https://doi.org/10.1016/j.fct.2021.112591

doi: 10.1016/j.fct.2021.112591 pubmed: 34614429

Campbell A et al (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75(4):565–572. https://doi.org/10.1002/jnr.10877

doi: 10.1002/jnr.10877 pubmed: 14743440

Ogawa M, Kayama F (2015) A study of the association between urinary aluminum concentration and pre-clinical findings among aluminum-handling and non-handling workers. J Occup Med Toxicol 10:13. https://doi.org/10.1186/s12995-015-0055-8

doi: 10.1186/s12995-015-0055-8 pubmed: 25866547 pmcid: 4393619

Prakash D, Gopinath K, Sudhandiran G (2013) Fisetin enhances behavioral performances and attenuates reactive gliosis and inflammation during aluminum chloride-induced neurotoxicity. Neuromolecular Med 15(1):192–208. https://doi.org/10.1007/s12017-012-8210-1

doi: 10.1007/s12017-012-8210-1 pubmed: 23315010

Zaky A et al (2017) A Combination of resveratrol and curcumin is effective against aluminum chloride-induced neuroinflammation in rats. J Alzheimers Dis 60(s1):S221-s235. https://doi.org/10.3233/jad-161115

doi: 10.3233/jad-161115 pubmed: 28222524

Barceloux DG (1999) Copper. J Toxicol Clin Toxicol 37(2):217–230. https://doi.org/10.1081/clt-100102421

doi: 10.1081/clt-100102421 pubmed: 10382557

Araya M et al (2003) Copper exposure and potential biomarkers of copper metabolism. Biometals 16(1):199–204. https://doi.org/10.1023/a:1020723117584

doi: 10.1023/a:1020723117584 pubmed: 12572679

Scheiber IF, Dringen R (2013) Astrocyte functions in the copper homeostasis of the brain. Neurochem Int 62(5):556–565. https://doi.org/10.1016/j.neuint.2012.08.017

doi: 10.1016/j.neuint.2012.08.017 pubmed: 22982300

Taylor AA et al (2023) Recommended reference values for risk assessment of oral exposure to copper. Risk Anal 43(2):211–218. https://doi.org/10.1111/risa.13906

doi: 10.1111/risa.13906 pubmed: 35194835

Zaidel A, Ma WJ, Angelaki DE (2013) Supervised calibration relies on the multisensory percept. Neuron 80(6):1544–1557. https://doi.org/10.1016/j.neuron.2013.09.026

doi: 10.1016/j.neuron.2013.09.026 pubmed: 24290205

Ozcelik D, Uzun H (2009) Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 127(1):45–52. https://doi.org/10.1007/s12011-008-8219-3

doi: 10.1007/s12011-008-8219-3 pubmed: 18784908

Kaler SG (2011) ATP7A-related copper transport diseases-emerging concepts and future trends. Nat Rev Neurol 7(1):15–29. https://doi.org/10.1038/nrneurol.2010.180

doi: 10.1038/nrneurol.2010.180 pubmed: 21221114 pmcid: 4214867

Burkhead JL, Gray LW, Lutsenko S (2011) Systems biology approach to Wilson’s disease. Biometals 24(3):455–466. https://doi.org/10.1007/s10534-011-9430-9

doi: 10.1007/s10534-011-9430-9 pubmed: 21380607 pmcid: 3106420

Brewer GJ (2014) Alzheimer’s disease causation by copper toxicity and treatment with zinc. Front Aging Neurosci 6:92. https://doi.org/10.3389/fnagi.2014.00092

doi: 10.3389/fnagi.2014.00092 pubmed: 24860501 pmcid: 4030141

Montes S et al (2014) Copper and copper proteins in Parkinson’s disease. Oxid Med Cell Longev 2014:147251. https://doi.org/10.1155/2014/147251

doi: 10.1155/2014/147251 pubmed: 24672633 pmcid: 3941957

Bourassa MW et al (2014) Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS. Front Aging Neurosci 6:110. https://doi.org/10.3389/fnagi.2014.00110

doi: 10.3389/fnagi.2014.00110 pubmed: 24982630 pmcid: 4059277

Voss K et al (2014) Modulation of tau phosphorylation by environmental copper. Transl Neurodegener 3(1):24. https://doi.org/10.1186/2047-9158-3-24

doi: 10.1186/2047-9158-3-24 pubmed: 25671100 pmcid: 4322670

Schrag M et al (2013) Oxidative stress in blood in Alzheimer’s disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis 59:100–110. https://doi.org/10.1016/j.nbd.2013.07.005

doi: 10.1016/j.nbd.2013.07.005 pubmed: 23867235

Xiao G et al (2013) Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. Proc Natl Acad Sci U S A 110(37):14995–15000. https://doi.org/10.1073/pnas.1308535110

doi: 10.1073/pnas.1308535110 pubmed: 23980182 pmcid: 3773747

Castro PA et al (2014) Copper-uptake is critical for the down regulation of synapsin and dynamin induced by neocuproine: modulation of synaptic activity in hippocampal neurons. Front Aging Neurosci 6:319. https://doi.org/10.3389/fnagi.2014.00319

doi: 10.3389/fnagi.2014.00319 pubmed: 25520655 pmcid: 4253966

De Riccardis L et al (2018) Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects. Biochim Biophys Acta Mol Basis Dis 1846(5 Pt A):1828–1838. https://doi.org/10.1016/j.bbadis.2018.03.007

doi: 10.1016/j.bbadis.2018.03.007

Kitazawa M, Hsu HW, Medeiros R (2016) Copper exposure perturbs brain inflammatory responses and impairs clearance of amyloid-beta. Toxicol Sci 152(1):194–204. https://doi.org/10.1093/toxsci/kfw081

doi: 10.1093/toxsci/kfw081 pubmed: 27122238 pmcid: 4922545

Pereira TC, Campos MM, Bogo MR (2016) Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model. J Appl Toxicol 36(7):876–885. https://doi.org/10.1002/jat.3303

doi: 10.1002/jat.3303 pubmed: 26888422

Choo XY et al (2013) Neuroinflammation and copper in Alzheimer’s disease. Int J Alzheimers Dis 2013:145345. https://doi.org/10.1155/2013/145345

doi: 10.1155/2013/145345 pubmed: 24369524 pmcid: 3863554

Lu J et al (2009) Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Brain Behav Immun 23(2):193–203. https://doi.org/10.1016/j.bbi.2008.09.003

doi: 10.1016/j.bbi.2008.09.003 pubmed: 18835350

Sarawi WS et al (2021) Curcumin and nano-curcumin mitigate copper neurotoxicity by modulating oxidative stress, inflammation, and Akt/GSK-3β signaling. Molecules 26(18). https://doi.org/10.3390/molecules26185591

Chen J et al (2023) Low-dose Cu exposure enhanced α-synuclein accumulation associates with mitochondrial impairments in mice model of Parkinson’s disease. Toxicol Lett 387:14–27. https://doi.org/10.1016/j.toxlet.2023.09.004

doi: 10.1016/j.toxlet.2023.09.004 pubmed: 37717680

Zucconi GG et al (2007) Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders. Neuropathol Appl Neurobiol 33(2):212–225. https://doi.org/10.1111/j.1365-2990.2006.00793.x

doi: 10.1111/j.1365-2990.2006.00793.x pubmed: 17359362

Jensen A, Bro-Rasmussen F (1992) Environmental cadmium in Europe. Rev Environ Contam Toxicol 125:101–181. https://doi.org/10.1007/978-1-4612-2890-5_3

doi: 10.1007/978-1-4612-2890-5_3 pubmed: 1509176

Ragan HA (1983) The bioavailability of iron, lead and cadmium via gastrointestinal absorption: a review. Sci Total Environ 28:317–326. https://doi.org/10.1016/s0048-9697(83)80029-1

doi: 10.1016/s0048-9697(83)80029-1 pubmed: 6348941

Swiergosz-Kowalewska R (2001) Cadmium distribution and toxicity in tissues of small rodents. Microsc Res Tech 55(3):208–222. https://doi.org/10.1002/jemt.1171

doi: 10.1002/jemt.1171 pubmed: 11747096

Horiguchi H et al (2010) Latest status of cadmium accumulation and its effects on kidneys, bone, and erythropoiesis in inhabitants of the formerly cadmium-polluted Jinzu River Basin in Toyama, Japan, after restoration of rice paddies. Int Arch Occup Environ Health 83(8):953–970. https://doi.org/10.1007/s00420-010-0510-x

doi: 10.1007/s00420-010-0510-x pubmed: 20130905

Yang Z et al (2007) Cadmium-induced toxicity in rat primary mid-brain neuroglia cultures: role of oxidative stress from microglia. Toxicol Sci 98(2):488–494. https://doi.org/10.1093/toxsci/kfm106

doi: 10.1093/toxsci/kfm106 pubmed: 17483498

Ciesielski T et al (2013) Associations between cadmium exposure and neurocognitive test scores in a cross-sectional study of US adults. Environ Health 12:13. https://doi.org/10.1186/1476-069x-12-13

doi: 10.1186/1476-069x-12-13 pubmed: 23379984 pmcid: 3599125

Ciesielski T et al (2012) Cadmium exposure and neurodevelopmental outcomes in U.S. children. Environ Health Perspect 120(5):758–63. https://doi.org/10.1289/ehp.1104152

doi: 10.1289/ehp.1104152 pubmed: 22289429 pmcid: 3346779

Min JY, Min KB (2016) Blood cadmium levels and Alzheimer’s disease mortality risk in older US adults. Environ Health 15(1):69. https://doi.org/10.1186/s12940-016-0155-7

doi: 10.1186/s12940-016-0155-7 pubmed: 27301955 pmcid: 4908725

Kim JA et al (2012) Heavy metal risk management: case analysis. Toxicol Res 28(3):143–149. https://doi.org/10.5487/tr.2012.28.3.143

doi: 10.5487/tr.2012.28.3.143 pubmed: 24278603 pmcid: 3834422

Omarova A, Phillips CJ (2007) A meta-analysis of literature data relating to the relationships between cadmium intake and toxicity indicators in humans. Environ Res 103(3):432–440. https://doi.org/10.1016/j.envres.2006.09.006

doi: 10.1016/j.envres.2006.09.006 pubmed: 17109840

Chatterjee M, Kortenkamp A (2022) Cadmium exposures and deteriorations of cognitive abilities: estimation of a reference dose for mixture risk assessments based on a systematic review and confidence rating. Environ Health 21(1):69. https://doi.org/10.1186/s12940-022-00881-9

doi: 10.1186/s12940-022-00881-9 pubmed: 35836177 pmcid: 9281031

Rani A et al (2014) Cellular mechanisms of cadmium-induced toxicity: a review. Int J Environ Health Res 24(4):378–399. https://doi.org/10.1080/09603123.2013.835032

doi: 10.1080/09603123.2013.835032 pubmed: 24117228

Xu C et al (2016) Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A. Neuropharmacology 105:270–284. https://doi.org/10.1016/j.neuropharm.2016.01.030

doi: 10.1016/j.neuropharm.2016.01.030 pubmed: 26805420 pmcid: 4873321

Zhao R et al (2020) Cadmium induces mitochondrial ROS inactivation of XIAP pathway leading to apoptosis in neuronal cells. Int J Biochem Cell Biol 121:105715. https://doi.org/10.1016/j.biocel.2020.105715

doi: 10.1016/j.biocel.2020.105715 pubmed: 32035180 pmcid: 7045337

Huat TJ et al (2019) Metal toxicity links to Alzheimer’s disease and neuroinflammation. J Mol Biol 431(9):1843–1868. https://doi.org/10.1016/j.jmb.2019.01.018

doi: 10.1016/j.jmb.2019.01.018 pubmed: 30664867 pmcid: 6475603

Phuagkhaopong S et al (2017) Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB pathways. Neurotoxicology 60:82–91. https://doi.org/10.1016/j.neuro.2017.03.001

doi: 10.1016/j.neuro.2017.03.001 pubmed: 28288823

Yuan Y et al (2015) The role of mitogen-activated protein kinase in cadmium-induced primary rat cerebral cortical neurons apoptosis via a mitochondrial apoptotic pathway. J Trace Elem Med Biol 29:275–283. https://doi.org/10.1016/j.jtemb.2014.06.006

doi: 10.1016/j.jtemb.2014.06.006 pubmed: 25043952

Park YK, Hong H, Jang BC (2012) Transcriptional and translational regulation of COX-2 expression by cadmium in C6 glioma cells. Int J Mol Med 30(4):960–966. https://doi.org/10.3892/ijmm.2012.1052

doi: 10.3892/ijmm.2012.1052 pubmed: 22767315

Cai J et al (2021) NLRP3 inflammasome mediated pyroptosis is involved in cadmium exposure-induced neuroinflammation through the IL-1β/IkB-α-NF-κB-NLRP3 feedback loop in swine. Toxicology 453:152720. https://doi.org/10.1016/j.tox.2021.152720

doi: 10.1016/j.tox.2021.152720 pubmed: 33592257

Khan A et al (2019) Caffeine modulates cadmium-induced oxidative stress, neuroinflammation, and cognitive impairments by regulating Nrf-2/HO-1 In vivo and in vitro. J Clin Med 8(5). https://doi.org/10.3390/jcm8050680

Alam SI et al (2021) Alpha-linolenic acid impedes cadmium-induced oxidative stress, neuroinflammation, and neurodegeneration in mouse brain. Cells 10(9). https://doi.org/10.3390/cells10092274

Kim J, Lee Y, Yang M (2014) Environmental exposure to lead (Pb) and variations in its susceptibility. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 32(2):159–185. https://doi.org/10.1080/10590501.2014.907461

doi: 10.1080/10590501.2014.907461 pubmed: 24875442

Brown EE et al (2019) Lead (Pb) in Alzheimer’s dementia: a systematic review of human case- control studies. Curr Alzheimer Res 16(4):353–361. https://doi.org/10.2174/1567205016666190311101445

doi: 10.2174/1567205016666190311101445 pubmed: 30854970

Machoń-Grecka A et al (2022) Angiogenesis and lead (Pb): is there a connection? Drug Chem Toxicol 45(2):589–593. https://doi.org/10.1080/01480545.2020.1734607

doi: 10.1080/01480545.2020.1734607 pubmed: 32126859

Cory-Slechta DA (1990) Lead exposure during advanced age: alterations in kinetics and biochemical effects. Toxicol Appl Pharmacol 104(1):67–78. https://doi.org/10.1016/0041-008x(90)90283-z

doi: 10.1016/0041-008x(90)90283-z pubmed: 2360209

Reuben A (2018) Childhood lead exposure and adult neurodegenerative disease. J Alzheimers Dis 64(1):17–42. https://doi.org/10.3233/jad-180267

doi: 10.3233/jad-180267 pubmed: 29865081 pmcid: 6454899

Hauptman M et al (2021) Individual- and community-level factors associated with detectable and elevated blood lead levels in US children: results from a national clinical laboratory. JAMA Pediatr 175(12):1252–1260. https://doi.org/10.1001/jamapediatrics.2021.3518

doi: 10.1001/jamapediatrics.2021.3518 pubmed: 34570188

Reuben A et al (2020) Association of childhood lead exposure with MRI measurements of structural brain integrity in midlife. JAMA 324(19):1970–1979. https://doi.org/10.1001/jama.2020.19998

doi: 10.1001/jama.2020.19998 pubmed: 33201203

Allen KA (2015) Is prenatal lead exposure a concern in infancy? What is the evidence? Adv Neonatal Care 15(6):416–420. https://doi.org/10.1097/anc.0000000000000224

doi: 10.1097/anc.0000000000000224 pubmed: 26372041

Ettinger AS et al (2004) Effect of breast milk lead on infant blood lead levels at 1 month of age. Environ Health Perspect 112(14):1381–1385. https://doi.org/10.1289/ehp.6616

doi: 10.1289/ehp.6616 pubmed: 15471729 pmcid: 1247564

Jakubowski M (2011) Low-level environmental lead exposure and intellectual impairment in children–the current concepts of risk assessment. Int J Occup Med Environ Health 24(1):1–7. https://doi.org/10.2478/s13382-011-0009-z

doi: 10.2478/s13382-011-0009-z pubmed: 21468897

Garza A, Vega R, Soto E (2006) Cellular mechanisms of lead neurotoxicity. Med Sci Monit 12(3):Ra57-65

pubmed: 16501435

Kumawat KL et al (2014) Acute exposure to lead acetate activates microglia and induces subsequent bystander neuronal death via caspase-3 activation. Neurotoxicology 41:143–153. https://doi.org/10.1016/j.neuro.2014.02.002

doi: 10.1016/j.neuro.2014.02.002 pubmed: 24530660

He P et al (2021) Blood lead, systemic inflammation, and blood pressure: exploring associations and mediation effects in workers exposed to lead. Biol Trace Elem Res 199(7):2573–2581. https://doi.org/10.1007/s12011-020-02397-0

doi: 10.1007/s12011-020-02397-0 pubmed: 32959337

Kasten-Jolly J, Heo Y, Lawrence DA (2011) Central nervous system cytokine gene expression: modulation by lead. J Biochem Mol Toxicol 25(1):41–54. https://doi.org/10.1002/jbt.20358

doi: 10.1002/jbt.20358 pubmed: 21322097 pmcid: 3635043

Li N et al (2015) The effects of early life lead exposure on the expression of interleukin (IL) 1β, IL-6, and glial fibrillary acidic protein in the hippocampus of mouse pups. Hum Exp Toxicol 34(4):357–363. https://doi.org/10.1177/0960327114529451

doi: 10.1177/0960327114529451 pubmed: 25028260

Yang W et al (2019) Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway. Food Chem Toxicol 134:110824. https://doi.org/10.1016/j.fct.2019.110824

doi: 10.1016/j.fct.2019.110824 pubmed: 31539617

Liu JT et al (2015) Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFκB signaling cascades. Toxicol Lett 239(2):97–107. https://doi.org/10.1016/j.toxlet.2015.09.015

doi: 10.1016/j.toxlet.2015.09.015 pubmed: 26386401

Lu LL et al (2022) Therapeutic effects of sodium para-aminosalicylic acid on cognitive deficits and activated ERK1/2-p90(RSK)/NF-κB inflammatory pathway in Pb-exposed rats. Biol Trace Elem Res 200(6):2807–2815. https://doi.org/10.1007/s12011-021-02874-0

doi: 10.1007/s12011-021-02874-0 pubmed: 34398420

Aschner M, Erikson K (2017) Manganese. Adv Nutr 8(3):520–521. https://doi.org/10.3945/an.117.015305

doi: 10.3945/an.117.015305 pubmed: 28507016 pmcid: 5421128

Balachandran RC et al (2020) Brain manganese and the balance between essential roles and neurotoxicity. J Biol Chem 295(19):6312–6329. https://doi.org/10.1074/jbc.REV119.009453

doi: 10.1074/jbc.REV119.009453 pubmed: 32188696 pmcid: 7212623

Aydemir TB et al (2020) Intestine-specific deletion of metal transporter Zip14 (Slc39a14) causes brain manganese overload and locomotor defects of manganism. Am J Physiol Gastrointest Liver Physiol 318(4):G673-g681. https://doi.org/10.1152/ajpgi.00301.2019

doi: 10.1152/ajpgi.00301.2019 pubmed: 32003605 pmcid: 7191460

Milton B et al (2017) Modeling U-shaped dose-response curves for manganese using categorical regression. Neurotoxicology 58:217–225. https://doi.org/10.1016/j.neuro.2016.10.001

doi: 10.1016/j.neuro.2016.10.001 pubmed: 27720796

Finley JW (2004) Does environmental exposure to manganese pose a health risk to healthy adults? Nutr Rev 62(4):148–153. https://doi.org/10.1111/j.1753-4887.2004.tb00037.x

doi: 10.1111/j.1753-4887.2004.tb00037.x pubmed: 15141430

Zoni S, Lucchini RG (2013) Manganese exposure: cognitive, motor and behavioral effects on children: a review of recent findings. Curr Opin Pediatr 25(2):255–260. https://doi.org/10.1097/MOP.0b013e32835e906b

doi: 10.1097/MOP.0b013e32835e906b pubmed: 23486422 pmcid: 4073890

Bowler RM et al (2011) Prospective study on neurotoxic effects in manganese-exposed bridge construction welders. Neurotoxicology 32(5):596–605. https://doi.org/10.1016/j.neuro.2011.06.004

doi: 10.1016/j.neuro.2011.06.004 pubmed: 21762725

Haynes EN et al (2015) Manganese exposure and neurocognitive outcomes in rural school-age children: the communities actively researching exposure study (Ohio, USA). Environ Health Perspect 123(10):1066–1071. https://doi.org/10.1289/ehp.1408993

doi: 10.1289/ehp.1408993 pubmed: 25902278 pmcid: 4590758

Carvalho CF et al (2014) Elevated airborne manganese and low executive function in school-aged children in Brazil. Neurotoxicology 45:301–308. https://doi.org/10.1016/j.neuro.2013.11.006

doi: 10.1016/j.neuro.2013.11.006 pubmed: 24308913

Budinger D et al (2021) The role of manganese dysregulation in neurological disease: emerging evidence. Lancet Neurol 20(11):956–968. https://doi.org/10.1016/s1474-4422(21)00238-6

doi: 10.1016/s1474-4422(21)00238-6 pubmed: 34687639

Chen CJ et al (2006) Manganese modulates pro-inflammatory gene expression in activated glia. Neurochem Int 49(1):62–71. https://doi.org/10.1016/j.neuint.2005.12.020

doi: 10.1016/j.neuint.2005.12.020 pubmed: 16488514

Tjalkens RB, Popichak KA, Kirkley KA (2017) Inflammatory activation of microglia and astrocytes in manganese neurotoxicity. Adv Neurobiol 18:159–181. https://doi.org/10.1007/978-3-319-60189-2_8

doi: 10.1007/978-3-319-60189-2_8 pubmed: 28889267 pmcid: 6462217

Aschner M, Gannon M, Kimelberg HK (1992) Manganese uptake and efflux in cultured rat astrocytes. J Neurochem 58(2):730–735. https://doi.org/10.1111/j.1471-4159.1992.tb09778.x

doi: 10.1111/j.1471-4159.1992.tb09778.x pubmed: 1729413

Morello M et al (2008) Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicology 29(1):60–72. https://doi.org/10.1016/j.neuro.2007.09.001

doi: 10.1016/j.neuro.2007.09.001 pubmed: 17936361

Sidoryk-Wegrzynowicz M, Aschner M (2013) Manganese toxicity in the central nervous system: the glutamine/glutamate-γ-aminobutyric acid cycle. J Intern Med 273(5):466–477. https://doi.org/10.1111/joim.12040

doi: 10.1111/joim.12040 pubmed: 23360507 pmcid: 3633698

Popichak KA et al (2018) Glial-neuronal signaling mechanisms underlying the neuroinflammatory effects of manganese. J Neuroinflammation 15(1):324. https://doi.org/10.1186/s12974-018-1349-4

doi: 10.1186/s12974-018-1349-4 pubmed: 30463564 pmcid: 6247759

Moreno JA et al (2008) Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways. J Neurosci Res 86(9):2028–2038. https://doi.org/10.1002/jnr.21640

doi: 10.1002/jnr.21640 pubmed: 18335517 pmcid: 4618683

Perl DP, Olanow CW (2007) The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 66(8):675–682. https://doi.org/10.1097/nen.0b013e31812503cf

doi: 10.1097/nen.0b013e31812503cf pubmed: 17882011

Qi Z et al (2019) The effect of manganese exposure on GnRH secretion via Nrf2/mGluR5/COX-2/PGE2/signaling pathway. Toxicol Ind Health 35(3):211–227. https://doi.org/10.1177/0748233719825720

doi: 10.1177/0748233719825720 pubmed: 30862296

Nkpaa KW et al (2019) Ethanol via regulation of NF-κB/p53 signaling pathway increases manganese-induced inflammation and apoptosis in hypothalamus of rats. Biol Trace Elem Res 190(1):101–108. https://doi.org/10.1007/s12011-018-1535-3

doi: 10.1007/s12011-018-1535-3 pubmed: 30284675

Pajarillo E et al (2022) Deletion of RE1-silencing transcription factor in striatal astrocytes exacerbates manganese-induced neurotoxicity in mice. Glia 70(10):1886–1901. https://doi.org/10.1002/glia.24226

doi: 10.1002/glia.24226 pubmed: 35638297 pmcid: 9378447

Wang D et al (2017) The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability. Autophagy 13(5):914–927. https://doi.org/10.1080/15548627.2017.1293766

doi: 10.1080/15548627.2017.1293766 pubmed: 28318352 pmcid: 5446056

Saper RB, Rash R (2009) Zinc: an essential micronutrient. Am Fam Physician 79(9):768–772

pubmed: 20141096 pmcid: 2820120

Prasad AS (2007) Zinc: mechanisms of host defense. J Nutr 137(5):1345–1349. https://doi.org/10.1093/jn/137.5.1345

doi: 10.1093/jn/137.5.1345 pubmed: 17449604

Moran VH et al (2012) The relationship between zinc intake and serum/plasma zinc concentration in pregnant and lactating women: a systematic review with dose-response meta-analyses. J Trace Elem Med Biol 26(2–3):74–79. https://doi.org/10.1016/j.jtemb.2012.04.003

doi: 10.1016/j.jtemb.2012.04.003 pubmed: 22613060

Frederickson CJ, Moncrieff DW (1994) Zinc-containing neurons. Biol Signals 3(3):127–139. https://doi.org/10.1159/000109536

doi: 10.1159/000109536 pubmed: 7531563

Takeda A (2000) Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 34(3):137–148. https://doi.org/10.1016/s0165-0173(00)00044-8

doi: 10.1016/s0165-0173(00)00044-8 pubmed: 11113504

Szewczyk B, Kubera M, Nowak G (2011) The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):693–701. https://doi.org/10.1016/j.pnpbp.2010.02.010

doi: 10.1016/j.pnpbp.2010.02.010 pubmed: 20156515

Kumar A et al (2010) Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 44(8):950–965. https://doi.org/10.3109/10715762.2010.492832

doi: 10.3109/10715762.2010.492832 pubmed: 20553223

Dexter DT et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953–1975. https://doi.org/10.1093/brain/114.4.1953

doi: 10.1093/brain/114.4.1953 pubmed: 1832073

Kumar A et al (2012) Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity. Brain Res 1438:48–64. https://doi.org/10.1016/j.brainres.2011.12.028

doi: 10.1016/j.brainres.2011.12.028 pubmed: 22244881

Kawahara M et al (2014) Disruption of zinc homeostasis and the pathogenesis of senile dementia. Metallomics 6(2):209–219. https://doi.org/10.1039/c3mt00257h

doi: 10.1039/c3mt00257h pubmed: 24247360

Vilella A et al (2018) Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery. J Trace Elem Med Biol 49:210–221. https://doi.org/10.1016/j.jtemb.2017.12.006

doi: 10.1016/j.jtemb.2017.12.006 pubmed: 29325805

Mocchegiani E et al (2013) Zinc: dietary intake and impact of supplementation on immune function in elderly. Age 35(3):839–860. https://doi.org/10.1007/s11357-011-9377-3 . (Dordr)

doi: 10.1007/s11357-011-9377-3 pubmed: 22222917

Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12(6):646–652. https://doi.org/10.1097/MCO.0b013e3283312956

doi: 10.1097/MCO.0b013e3283312956 pubmed: 19710611

Hamada T et al (2020) Zinc-aggravated M1 microglia regulate astrocytic engulfment via P2×7 receptors. J Trace Elem Med Biol 61:126518. https://doi.org/10.1016/j.jtemb.2020.126518

doi: 10.1016/j.jtemb.2020.126518 pubmed: 32353820

Higashi Y et al (2011) Microglial zinc uptake via zinc transporters induces ATP release and the activation of microglia. Glia 59(12):1933–1945. https://doi.org/10.1002/glia.21235

doi: 10.1002/glia.21235 pubmed: 22253048

Rivers-Auty J et al (2021) Zinc status alters Alzheimer’s disease progression through NLRP3-dependent inflammation. J Neurosci 41(13):3025–3038. https://doi.org/10.1523/jneurosci.1980-20.2020

doi: 10.1523/jneurosci.1980-20.2020 pubmed: 33597269 pmcid: 8018890

Chauhan AK et al (2016) Inflammation and B-cell lymphoma-2 associated X protein Regulate zinc-induced apoptotic degeneration of rat nigrostriatal dopaminergic neurons. Mol Neurobiol 53(8):5782–5795. https://doi.org/10.1007/s12035-015-9478-6

doi: 10.1007/s12035-015-9478-6 pubmed: 26497033

D’Orazio N et al (2012) Marine bioactives: pharmacological properties and potential applications against inflammatory diseases. Mar Drugs 10(4):812–833. https://doi.org/10.3390/md10040812

doi: 10.3390/md10040812 pubmed: 22690145 pmcid: 3366677

Cesário R et al (2018) Mercury and methylmercury transport and fate in the water column of Tagus estuary (Portugal). Mar Pollut Bull 127:235–250. https://doi.org/10.1016/j.marpolbul.2017.11.066

doi: 10.1016/j.marpolbul.2017.11.066 pubmed: 29475660

Sakamoto M, Nakamura M, Murata K (2018) Mercury as a global pollutant and mercury exposure assessment and health effects. Nihon Eiseigaku Zasshi 73(3):258–264. https://doi.org/10.1265/jjh.73.258

doi: 10.1265/jjh.73.258 pubmed: 30270289

2nd Clifton JC (2007) Mercury exposure and public health. Pediatr Clin North Am 54(2):237–69, viii. https://doi.org/10.1016/j.pcl.2007.02.005

Eto K (2000) Minamata disease. Neuropathology 20(Suppl):S14–S19. https://doi.org/10.1046/j.1440-1789.2000.00295.x

doi: 10.1046/j.1440-1789.2000.00295.x pubmed: 11037181

Xu F et al (2012) Mercury-induced toxicity of rat cortical neurons is mediated through N-methyl-D-aspartate receptors. Mol Brain 5:30. https://doi.org/10.1186/1756-6606-5-30

doi: 10.1186/1756-6606-5-30 pubmed: 22980357 pmcid: 3462706

Johnson FO, Atchison WD (2009) The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology 30(5):761–765. https://doi.org/10.1016/j.neuro.2009.07.010

doi: 10.1016/j.neuro.2009.07.010 pubmed: 19632272 pmcid: 2761528

Praline J et al (2007) ALS and mercury intoxication: a relationship? Clin Neurol Neurosurg 109(10):880–883. https://doi.org/10.1016/j.clineuro.2007.07.008

doi: 10.1016/j.clineuro.2007.07.008 pubmed: 17719172

Mutter J et al (2004) Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuro Endocrinol Lett 25(5):331–339

pubmed: 15580166

Bose-O'Reilly S et al (2017) Signs and symptoms of mercury-exposed gold miners. Int J Occup Med Environ Health 30(2):249–269. https://doi.org/10.13075/ijomeh.1896.00715

Sun YH et al (2015) Association between dental amalgam fillings and Alzheimer’s disease: a population-based cross-sectional study in Taiwan. Alzheimers Res Ther 7(1):65. https://doi.org/10.1186/s13195-015-0150-1

doi: 10.1186/s13195-015-0150-1 pubmed: 26560125 pmcid: 4642684

Fujimura M et al (2009) Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30(6):1000–1007. https://doi.org/10.1016/j.neuro.2009.08.001

doi: 10.1016/j.neuro.2009.08.001 pubmed: 19666049

Carvalho LVB et al (2019) Oxidative stress levels induced by mercury exposure in Amazon juvenile populations in Brazil. Int J Environ Res Public Health 16(15). https://doi.org/10.3390/ijerph16152682

Liu W et al (2019) Methyl-mercury induces apoptosis through ROS-mediated endoplasmic reticulum stress and mitochondrial apoptosis pathways activation in rat cortical neurons. Free Radic Res 53(1):26–44. https://doi.org/10.1080/10715762.2018.1546852

doi: 10.1080/10715762.2018.1546852 pubmed: 30513015

Yang L et al (2020) Toxicity of mercury: molecular evidence. Chemosphere 245:125586. https://doi.org/10.1016/j.chemosphere.2019.125586

doi: 10.1016/j.chemosphere.2019.125586 pubmed: 31881386

Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32(1):1–14

doi: 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W pubmed: 10975906

Shanker G et al (2005) Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Brain Res Mol Brain Res 137(1–2):11–22. https://doi.org/10.1016/j.molbrainres.2005.02.006

doi: 10.1016/j.molbrainres.2005.02.006 pubmed: 15950756

Pollard KM et al (2019) Mercury-induced inflammation and autoimmunity. Biochim Biophys Acta Gen Subj 1863(12):129299. https://doi.org/10.1016/j.bbagen.2019.02.001

doi: 10.1016/j.bbagen.2019.02.001 pubmed: 30742953 pmcid: 6689266

Shanker G, Syversen T, Aschner M (2003) Astrocyte-mediated methylmercury neurotoxicity. Biol Trace Elem Res 95(1):1–10. https://doi.org/10.1385/bter:95:1:1

doi: 10.1385/bter:95:1:1 pubmed: 14555794

Gardner RM et al (2010) Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study. Environ Res 110(4):345–354. https://doi.org/10.1016/j.envres.2010.02.001

doi: 10.1016/j.envres.2010.02.001 pubmed: 20176347 pmcid: 2873228

Nyland JF et al (2011) Biomarkers of methylmercury exposure immunotoxicity among fish consumers in Amazonian Brazil. Environ Health Perspect 119(12):1733–1738. https://doi.org/10.1289/ehp.1103741

doi: 10.1289/ehp.1103741 pubmed: 21868305 pmcid: 3261989

Garg TK, Chang JY (2006) Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. J Neuroimmunol 171(1–2):17–28. https://doi.org/10.1016/j.jneuroim.2005.09.007

doi: 10.1016/j.jneuroim.2005.09.007 pubmed: 16225932

Ni M et al (2011) Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia 59(5):810–820. https://doi.org/10.1002/glia.21153

doi: 10.1002/glia.21153 pubmed: 21351162 pmcid: 3080116

Alattar A et al (2022) Carveol ameliorates mercury-induced oxidative stress, neuroinflammation, and neurodegeneration in a mouse brain. Neurotoxicology 92:212–226. https://doi.org/10.1016/j.neuro.2022.08.006

doi: 10.1016/j.neuro.2022.08.006 pubmed: 35963490

Sharpe MA, Livingston AD, Baskin DS (2012) Thimerosal-derived ethylmercury is a mitochondrial toxin in human astrocytes: possible role of Fenton chemistry in the oxidation and breakage of mtDNA. J Toxicol 2012:373678. https://doi.org/10.1155/2012/373678

doi: 10.1155/2012/373678 pubmed: 22811707 pmcid: 3395253

Monastero RN et al (2017) Mercury exposure, serum antinuclear antibodies, and serum cytokine levels in the Long Island Study of Seafood Consumption: a cross-sectional study in NY, USA. Environ Res 156:334–340. https://doi.org/10.1016/j.envres.2017.03.037

doi: 10.1016/j.envres.2017.03.037 pubmed: 28390301

Lieu PT et al (2001) The roles of iron in health and disease. Mol Aspects Med 22(1–2):1–87. https://doi.org/10.1016/s0098-2997(00)00006-6

doi: 10.1016/s0098-2997(00)00006-6 pubmed: 11207374

Nairz M, Weiss G (2020) Iron in health and disease. Mol Aspects Med 75:100906. https://doi.org/10.1016/j.mam.2020.100906

doi: 10.1016/j.mam.2020.100906 pubmed: 32977976

Ward RJ et al (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045–1060. https://doi.org/10.1016/s1474-4422(14)70117-6

doi: 10.1016/s1474-4422(14)70117-6 pubmed: 25231526 pmcid: 5672917

Rodrigue KM et al (2020) Striatal iron content is linked to reduced fronto-striatal brain function under working memory load. Neuroimage 210:116544. https://doi.org/10.1016/j.neuroimage.2020.116544

doi: 10.1016/j.neuroimage.2020.116544 pubmed: 31972284

Godeau D et al (2021) Return-to-work, disabilities and occupational health in the age of COVID-19. Scand J Work Environ Health 47(5):408–409. https://doi.org/10.5271/sjweh.3960

doi: 10.5271/sjweh.3960 pubmed: 34003294 pmcid: 8259700

Camaschella C (2015) Iron-deficiency anemia. N Engl J Med 372(19):1832–1843. https://doi.org/10.1056/NEJMra1401038

doi: 10.1056/NEJMra1401038 pubmed: 25946282

Pasricha SR et al (2021) Iron deficiency. Lancet 397(10270):233–248. https://doi.org/10.1016/s0140-6736(20)32594-0

doi: 10.1016/s0140-6736(20)32594-0 pubmed: 33285139

Falkingham M et al (2010) The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J 9:4. https://doi.org/10.1186/1475-2891-9-4

doi: 10.1186/1475-2891-9-4 pubmed: 20100340 pmcid: 2831810

Rao SS et al (2020) The iron chelator deferiprone improves the phenotype in a mouse model of tauopathy. J Alzheimers Dis 77(2):753–771. https://doi.org/10.3233/jad-200551

doi: 10.3233/jad-200551 pubmed: 32741833

Abe N et al (2020) Microglia and Macrophages in the pathological central and peripheral nervous systems. Cells 9(9). https://doi.org/10.3390/cells9092132

Liu Z et al (2017) Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance. Sci Rep 7(1):14973. https://doi.org/10.1038/s41598-017-14721-1

doi: 10.1038/s41598-017-14721-1 pubmed: 29097764 pmcid: 5668412

de Farias CC et al (2017) Parkinson’s disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways. CNS Neurol Disord Drug Targets 16(4):484–491. https://doi.org/10.2174/1871527316666170223161004

doi: 10.2174/1871527316666170223161004 pubmed: 28240188

Xiong P et al (2012) Baicalin and deferoxamine alleviate iron accumulation in different brain regions of Parkinson’s disease rats. Neural Regen Res 7(27):2092–2098. https://doi.org/10.3969/j.issn.1673-5374.2012.27.002

doi: 10.3969/j.issn.1673-5374.2012.27.002 pubmed: 25558221 pmcid: 4281409

Gurel B et al (2018) Early stage alterations in CA1 extracellular region proteins indicate dysregulation of IL6 and iron homeostasis in the 5XFAD Alzheimer’s disease mouse model. J Alzheimers Dis 61(4):1399–1410. https://doi.org/10.3233/jad-170329

doi: 10.3233/jad-170329 pubmed: 29376847

Kaur D et al (2007) Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging 28(6):907–913. https://doi.org/10.1016/j.neurobiolaging.2006.04.003

doi: 10.1016/j.neurobiolaging.2006.04.003 pubmed: 16765489

Sayre LM et al (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer’s disease: a central role for bound transition metals. J Neurochem 74(1):270–279. https://doi.org/10.1046/j.1471-4159.2000.0740270.x

doi: 10.1046/j.1471-4159.2000.0740270.x pubmed: 10617129

D’Mello SR, Kindy MC (2020) Overdosing on iron: elevated iron and degenerative brain disorders. Exp Biol Med 245(16):1444–1473. https://doi.org/10.1177/1535370220953065 . (Maywood)

doi: 10.1177/1535370220953065

Yao MY et al (2021) Role of ferroptosis in neurological diseases. Neurosci Lett 747:135614. https://doi.org/10.1016/j.neulet.2020.135614

doi: 10.1016/j.neulet.2020.135614 pubmed: 33485988

Sun Y et al (2020) The emerging role of ferroptosis in inflammation. Biomed Pharmacother 127:110108. https://doi.org/10.1016/j.biopha.2020.110108

doi: 10.1016/j.biopha.2020.110108 pubmed: 32234642

Yu Y et al (2021) Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov 7(1):193. https://doi.org/10.1038/s41420-021-00579-w

doi: 10.1038/s41420-021-00579-w pubmed: 34312370 pmcid: 8313570

Qin XY et al (2016) Aberrations in peripheral inflammatory cytokine levels in parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316–1324. https://doi.org/10.1001/jamaneurol.2016.2742

doi: 10.1001/jamaneurol.2016.2742 pubmed: 27668667

Hinarejos I et al (2020) Mitochondrial dysfunction, oxidative stress and neuroinflammation in neurodegeneration with brain iron accumulation (NBIA). Antioxidants 9(10). https://doi.org/10.3390/antiox9101020 . (Basel)

Zhou Y et al (2018) Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway. Cancer Med 7(8):4012–4022. https://doi.org/10.1002/cam4.1670

doi: 10.1002/cam4.1670 pubmed: 29989329 pmcid: 6089144

Urrutia PJ, Bórquez DA, Núñez MT (2021) Inflaming the brain with iron. Antioxidants 10(1). https://doi.org/10.3390/antiox10010061 . (Basel)

Martin-Bastida A et al (2021) Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease. J Neural Transm 128(1):15–25. https://doi.org/10.1007/s00702-020-02271-2 . (Vienna)

doi: 10.1007/s00702-020-02271-2 pubmed: 33079260

Zhang W et al (2014) Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration. Mol Neurobiol 49(3):1153–1165. https://doi.org/10.1007/s12035-013-8586-4

doi: 10.1007/s12035-013-8586-4 pubmed: 24277523

Kenkhuis B et al (2021) Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients. Acta Neuropathol Commun 9(1):27. https://doi.org/10.1186/s40478-021-01126-5

doi: 10.1186/s40478-021-01126-5 pubmed: 33597025 pmcid: 7887813

Urati A et al (2022) Iron-induced cellular in vitro neurotoxic responses in rat C6 cell line. Environ Toxicol 37(8):1968–1978. https://doi.org/10.1002/tox.23543

doi: 10.1002/tox.23543 pubmed: 35446454

Xu Y et al (2020) Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP/PS1 mice. Free Radic Biol Med 158:84–95. https://doi.org/10.1016/j.freeradbiomed.2020.07.012

doi: 10.1016/j.freeradbiomed.2020.07.012 pubmed: 32707154

Sola E et al (2023) Cadmium-promoted thyroid hormones disruption mediates ROS, inflammation, Aβ and Tau proteins production, gliosis, spongiosis and neurodegeneration in rat basal forebrain. Chem Biol Interact 375:110428. https://doi.org/10.1016/j.cbi.2023.110428

doi: 10.1016/j.cbi.2023.110428 pubmed: 36868496

Branco V et al (2022) N-acetylcysteine or sodium selenite prevent the p38-mediated production of proinflammatory cytokines by microglia during exposure to mercury (II). Toxics 10(8). https://doi.org/10.3390/toxics10080433

Eskes C, Honegger P, Juillerat-Jeanneret L, Monnet-Tschudi F (2002) Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia. 37(1):43–52. https://doi.org/10.1002/glia.10019

doi: 10.1002/glia.10019 pubmed: 11746782

Prakash J et al (2014) Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res 39(12):2527–2536. https://doi.org/10.1007/s11064-014-1443-7

doi: 10.1007/s11064-014-1443-7 pubmed: 25403619

Zhang P et al (2020) Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson’s disease. Free Radic Biol Med 152:227–234. https://doi.org/10.1016/j.freeradbiomed.2020.03.015

doi: 10.1016/j.freeradbiomed.2020.03.015 pubmed: 32217194

Iłzecka J, Stelmasiak Z, Dobosz B (2001) Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients. Acta Neurol Scand 103(4):255–258

pubmed: 11328198

WHO (2021) World failing to address dementia challenge. Web. https://www.who.int/news/item/02-09-2021-world-failing-to-address-dementia-challenge

Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Ruokun Wei (R)

Peiqi Wei (P)

Haiyan Yuan (H)

Xiang Yi (X)

Michael Aschner (M)

Yue-Ming Jiang (YM)

Shao-Jun Li (SJ)

Classifications MeSH